Research methodology and epidemiology of relevance in recurrent pregnancy loss

Seminars in Reproductive Medicine

Volumn 24, Issue 1, 2006, Pages 5-16

  Christiansen, Ole B ^a   Nielsen, Henriette S ^a   Kolte, Astrid ^a   Pedersen, Anette T ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Abortion; Epidemiology; Pregnancy; Recurrent miscarriage; Research

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 5 LEIDEN; CARDIOLIPIN ANTIBODY; CHORIONIC GONADOTROPIN BETA SUBUNIT; CYTOKINE; DIETHYLSTILBESTROL; GESTAGEN; HLA ANTIGEN; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PLACEBO; PROGESTERONE; THYROID ANTIBODY;

ANTICOAGULANT THERAPY; CASE CONTROL STUDY; CLINICAL TRIAL; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE CLASSIFICATION; HEREDITY; HLA SYSTEM; HUMAN; IMMUNOTHERAPY; INFECTION; MATERNAL AGE; MEDICAL RESEARCH; METHODOLOGY; NATURAL KILLER CELL; OVARY POLYCYSTIC DISEASE; PREGNANCY OUTCOME; PROGNOSIS; RECURRENT ABORTION; REVIEW; RISK FACTOR; SAMPLING; SYSTEMATIC ERROR; TH1 CELL; THROMBOPHILIA; THYROID DISEASE; UTERUS MALFORMATION;

ABORTION, HABITUAL; FEMALE; HUMANS; PREGNANCY; RESEARCH DESIGN;

EID: 31144448129     PISSN: 15268004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10844-006-5447-x     Document Type: Review

References (60)

1. Beer AE, Quebbeman JF, Ayers JWT, Hainies RF. Major histocompatibility complex antigens, maternal and paternal immune responses, and chronic habitual abortions in humans. Am J Obstet Gynecol 1981;141:987-999
2. Unander AM, Norberg R, Hahn L, Arfors L. Anticardiolipin antibodies and complement in ninety-nine women with habituals abortion. Am J Obstet Gynecol 1987;156:114-119
3. Reznikoff-Etievant MF, Cayol V, Carbonne B, Robert A, Coulet F, Milliez J. Factor V Leiden and G20210A prothrombin mutations are risk factors for very early recurrent miscarriage. BJOG 2001;108:1251-1254
4. Aoki K, Kajiura S, Matsumoto Y, et al. Preconceptional natural killer cell activity as a predictor of miscarriage. Lancet 1995;345:1340-1342
5. Pfeiffer KA, Fimmers R, Engels G, van der Ven H, van der Ven K. The HLA-G genotype is potentially associated with idiopathic recurrent spontaneous abortion. Mol Hum Reprod 2001;7:373-378
6. Piccinni M, Beloni L, Livi C, Maggi E, Scarselli G, Romagnani S. Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nat Med 1998;4:1020-1023
7. Carp H, Salomon O, Seidman D, Dardik R, Rosenberg N, Inbal A. Prevalence of genetic markers for thrombophilia in recurent pregancy loss. Hum Reprod 2002;17:1633-1637
8. Sarig G, Younis JS, Hoffman R, Lanir N, Blumenfeld Z, Brenner B. Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage. Fertil Steril 2002;77:342-347
9. Grandone E, Margaglione M, Colaizzo D, et al. Factor V Leiden is associated with repeated and recurrent unexplained fetal losses. Thromb Haemost 1997;77:822-824
10. van Dunné FM, Doggen CJM, Heemskerk M, Rosendaal FR, Heimerhorst FM. Factor V Leiden mutation in relation to fecundity and miscarriage in women with venous thrombosis. Hum Reprod 2005;20:802-806
11. Ober C, Karrison T, Odem RR, et al. Mononuclear-cell immunisation in prevention of recurrent miscarriages: a randomised trial. Lancet 1999;354:365-369
12. Mowbray JF, Gibbings C, Liddell H, et al. Controlled trial of treatment of recurrent spontaneous abortions by immunization with paternal cells. Lancet 1985;I:941-943
13. Kutteh WH. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low dose aspirin is superior to low dose aspirin alone. Am J Obstet Gynecol 1996;174:1584-1589
14. Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin plus heparin in pregnant women with recurring miscarriage associated with antiphospholipid antibodies. BMJ 1997;314:253-257
15. Farquharson RG, Quenby S, Greaves M. Antiphosphlipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol 2002;100:408-413
16. Nybo Andersen AM, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal age and fetal loss: population based register linkage study. BMJ 2000;320:1708-1712
17. Cauchi MN, Coulam CB, Cowscock S, et al. Predictive factors in recurrent spontaneous aborters - A multicenter study. Am J Reprod Immunol 1995;33:165-170
18. Wramsby ML, Sten-Linder M, Bremme K. Primary habitual abortions are associated with high frequency of factor V Leiden mutation. Fertil Steril 2000;74:987-991
19. Christiansen OB, Pedersen B, Rosgaard A, Husth M. A randomized, double-blind, placebo-controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence for a therapeutic effect in women with secondary recurrent miscarriage. Hum Reprod 2002;17:809-816
20. Alexander SA, Latinne D, Debruyere M, Dupont E, Gottlieb W, Thomas K. Belgian experience with repeat immunization in recurrent spontaneous abortions. In: Beard RM, Sharp F, eds. Early Pregnancy Loss: Mechanisms and Treatment. London: Springer Verlag; 1988:355-363
21. Christiansen OB, Mathiesen O, Lauritsen JG, Grunnet N. Idiopathic recurrent spontaneous abortion. Evidence of a familial predisposition. Acta Obstet Gynecol Scand 1990;69:597-601
22. Ho H, Gill TJ, Hsieh C, Yang Y, Lee T. The prevalence of recurrent spontaneous abortions, cancer, and congenital anomalies in the families of couples with recurrent spontaneous abortions or gestational trophoblastic tumors. Am J Obstet Gynecol 1991;165:461-466
23. Emery AEH. Methodology in Medical Genetics. Edinburgh, United Kingdom: Churchill Livingstone; 1986
24. Christiansen OB, Andersen HH, Hojbjerre M, Kruse TA, Lauritzen SL, Grunnet N. Maternal HLA class II allogen-types are markers for the predisposition to fetal losses in families of women with unexplained recurrent fetal loss. Eur J Immunogenet 1995;22:323-334
25. Axelsson G, Rylander R. Validation of questionnaire reported miscarriage, malformation and birth weight. Int J Epidemiol 1984;13:94-98
26. Wilcox AJ, Horney LF. Accuracy of spontaneous abortion recall. Am J Epidemiol 1984;120:727-733
27. Coulam CB, Krysa L, Stern JJ, Bustillo M. Intravenous immnoglobulin for treatment of recurrent pregnancy loss. Am J Reprod Immunol 1995;34:333-337
28. Kruse C, Rosgaard A, Steffensen R, Varming K, Jensenius JC, Christiansen OB. Low serum level of mannan-binding lectin is a determinant for pregnancy outcome in women with recurrent spontaneous abortion. Am J Obstet Gynecol 2002;187:1313-1320
29. Creasy R. The cytogenetics of spontaneous abortion in humans. In: Beard RW, Sharp F, eds. Early Pregnancy Loss: Mechanisms and Treatment. London: Springer Verlag; 1988:293-304
30. Christiansen OB. A fresh look at the causes and treatments of recurrent miscarriage, especially its immunological aspects. Hum Reprod Update 1996;2:271-293
31. Ogasawara M, Aoki K, Okada S, et al. Embryonic karyotype of abortuses in relation to the number of previous miscarriages. Fertil Steril 2000;73:300-304
32. Out HJ, Bruinse HW, Christiaens GC, et al. Prevalence of antiphospholipid antibodies in patients with fetal loss. Ann Rheum Dis 1991;50:533-557
33. Byrd JR, Askew DE, McDonough PG. Cytogenetic findings in fifty-five couples with recurrent fetal wastage. Fertil Steril 1977;28:246-250
34. Christiansen OB, Rasmussen KL, Jersild C, Grunnet N. HLA class II alleles confer susceptibility to recurrent fetal losses in Danish women. Tissue Antigens 1994;44:225-233
35. Coulam CB. Immunological tests in the evaluation of reproductive disorders: a critical review. Am J Obstet Gynecol 1992;167:1844-1851
36. Ailus KT. A follow-up study of immunoglobulin levels and autoantibodies in an unselected pregnant population. Am J Reprod Immunol 1994;31:189-196
37. Topping J, Quenby S, Farquharson R, Malia R, Greaves M. Marked variation in antiphospholid antibodies during pregnancy: relationships to pregnancy outcome. Hum Reprod 1999;14:224-228
38. Makhseed M, Raghupathy R, Azizieh F, Omu A, Al-Shamali E, Ashkanani L. Th1 and Th2 cytokine profiles in recurrent aborters with successful pregnancy and with subsequent abortions. Hum Reprod 2001;16:2219-2226
39. Birkeland SA, Kristoffersen K. The fetus as an allograft: a longitudinal study of normal human pregnancies studied with mixed lymphocyte cultures between mother-father and mother-child. Scand J Immunol 1980;11:311-319
40. Birkeland SA, Kristoffersen K. Lymphocyte transformation with mitogens and antigens during normal human pregnancy: a longitudinal study. Scand J Immunol 1980;11:321-325
41. Michel M, Clark DA, Mowbray JF, Beard RW. Histologic and immunologic study of uterine biopsy tissue of women with incipient abortion. Am J Obstet Gynecol 1989;161:409-414
42. Yamamoto T, Takahashi Y, Kase N, Mori H. Decidual natural killer cells in recurrent spontaneous abortion with normal chromosomal content. Am J Reprod Immunol 1999;41:337-342
43. Piccinni M-P, Giudizi MG, Biagiotti R, et al. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol 1995;155:128-133
44. Szekeres-Bartho J, Faust Z, Varga P, et al. The immunological pregnancy protective effect of progesterone is manifested via controlling cytokine production. Am J Reprod Immunol 1996;35:348-351
45. Bradford-Hill A. The environment and disease: association or causation? Proc R Soc Med 1965;9:295-300
46. Jablonowska B, Selbing A, Palfi M, Ernerudh J, Kjellberg S, Lindton B. Prevention of recurrent spontaneous abortion by intravenous immunoglobulin: a double-blind placebo-controlled study. Hum Reprod 1999;14:838-841
47. Malpas P. A study of abortion sequences. J Obstet Gynaecol Br Empire 1938;45:932-949
48. Rai RS, Clifford K, Cohen H, Regan L. High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Hum Reprod 1995;10:3301-3304
49. Out HJ, Bruinse HW, Christiaens GCML, et al. A prospective, controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies. Am J Obstet Gynecol 1992;167:26-32
50. Nielsen HS, Christiansen OB. Prognostic impact of anti-cardiolipin antibodies in women with recurrent miscarriage negative for the lupus anticoagulant. Hum Reprod 2005;20:1720-1728
51. Gibb DMF, Salari DA. Transabdominal cervicoistmic cerclage in the management of recurrent second trimester miscarriage and preterm delivery. Br J Obstet Gynaecol 1995;102:802-806
52. Yudkin PL, Stratton IM. How to deal with regression to the mean in intervention studies. Lancet 1996;347:241-243
53. Christiansen OB. Transabdominal cervicoistmic cerclage in the management of recurrent second trimester miscarriage and preterm delivery [comment]. Br J Obstet Gynaecol 1996;103:595-596
54. Brenner B, Hoffman R, Blumenfeld Z, Weiner Z, Younis JS. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin. Thromb Haemost 2000;83:693-697
55. Grandone E, Brancaccio V, Colaizzo D, et al. Preventing adverse obsteric outcomes in women with genetic thrombophilia. Fertil Steril 2002;78:371-375
56. Reznikoff-Etievant MF. Immunotherapy for recurrent miscarriage. Consensus conference; July 16-17, 1993; Washington, DC. Am J Reprod Immunol 1994;32:257-302
57. Scott JR, Branch WD, Dudley DJ, Hatasaka HH. Immunotherapy for recurrent pregnancy loss: the University of Utah perspective. In: Dondero F, Johnson P, eds. Reproductive Immunology. Serono Symposium Publications. New York: Raven Press; 1997:255-257
58. Christiansen OB, Mathiesen O, Husth M, Lauritsen JG, Grunnet N. Placebo-controlled trial of active immunization with third party leukocytes in recurrent miscarriage. Acta Obstet Gynecol Scand 1994;73:261-268
59. Christiansen OB, Ring M, Rosgaard A, Grunnet N, Gluud C. Association between HLA-DR1 and -DR3 antigens and unexplained repeated miscarriage. Hum Reprod Update 1999;5:249-255
60. Christiansen OB, Andersen A-MN, Bosch E, et al. Evidence-based investigations and treatments of recurrent pregnancy loss. Fertil Steril 2005;83:821-839